Multiple Copies of Human Adenovirus 12 Genomes Are Integrated in Virus-Induced Hamster Tumors

Tumors induced in hamsters by highly oncogenic human adenovirus 12 contain multiple copies of 90 to 100% of the viral genome in an integrated form.     

Effects of chronic reserpine pretreatment on myocardial sodium pump and inotropic sensitivity to ouabain in guinea pig heart

The effects of chronic reserpine pretreatment (0.1 mg/kg/day, 7–9 days) on myocardial sodium pump activity, the binding of ³H-ouabain to Na⁺, K⁺-ATPase, and the positive inotropic effect of ouabain were studied in guinea pig hearts. Ouabain-sensitive ⁸⁶Rb uptake, an estimate of sodium pump activity, was significantly decreased (33.0%) in papillary muscles of chronic reserpine-pretreated guinea pigs as compared to the saline-treated controls. Kinetic analyses of the interaction of ³H-ouabain with Na⁺, K⁺-ATPase indicated that chronic reserpine pretreatment resulted in a significant decrease (24.3%) in the maximum ³H-ouabain binding site concentration when the results were expressed as pmoles per mg protein. The maximum ³H-ouabain binding sites or the number of Na⁺, K⁺-ATPase units, however, were not significantly different between the two groups when they were expressed as pmoles per mg DNA. The affinity or the dissociation rate constant (Kd) of ³H-ouabain binding was not altered after chronic reserpine pretreatment. In isolated, electrically-driven left atrial preparations, the basal contractile force was slightly higher in the reserpine-pretreated animals; the subsequent development of the positive inotropic effect and the concentration of ouabain needed to produce half-maximal inotropic response, however, were not different from the controls. Thus, it is concluded that chronic reserpine pretreatment is accompanied by a significant reduction in myocardial sodium pump activity; however, the number of sodium pump sites per cell was unchanged. The sensitivity of the reserpine-pretreated myocardium to the inotropic action of ouabain as well as its affinity for ³H-ouabain binding $\text{in vitro}$ are also unchanged.     

Triassic environments, climates and reptile evolution

A consideration of all the available data on Triassic vertebrate faunas, and their stratigraphic location reveals a relatively sudden extinction event among the last of the mammal-like reptiles and the herbivorous rhynchosaurs in the Norian of the Upper Triassic. This event was apparently quickly followed by the radiation of the dinosaurs, also in the Norian. This conclusion suggests that competition was not the main factor in the initial success of the dinosaurs, but opportunistic radiation following the extinction of major reptile groups. A global review of Triassic sedimentary facies shows that there were climatic and floral changes towards the end of the Triassic. It is envisaged that increasing aridity in the later Triassic, resulting from plate motions and particularly affecting Gondwanaland and southwestern Laurasia, brought about floral changes and then the reptile extinctions. With the rapid evolution of new floras of conifers and bennettitaleans, the dinosaurs came to dominate all terrestrial faunas within the space of only a few million years.     

Oxygen inhibition of photosynthesis in the C4 species Amaranthus graecizans L.

In the C₄ plant, Amaranthus graecizans, increasing [O₂] from 2% up to 100% inhibited photosynthesis, quantum yield, and the carboxylation efficiency, and increased the CO₂ compensation point () from 2 to about 12 l/l. The O₂ inhibition of photosynthesis was fully reversible. When changing from 2.5 to 40% O₂ and vice versa, about 1 h was required for full equilibration with an O₂ inhibition of 18%; whereas in wheat, a C₃ species, inhibition of photosynthesis and its reversal occurs within minutes after changing [O₂], resulting in 63% inhibition of photosynthesis by 45% O₂. These differences in O₂ inhibition between a C₄ and C₃ species can be explained by high diffusive resistance across bundle-sheath cells of C₄ plants and the increased CO₂/O₂ ratio in bundle-sheath cells which is the consequence of the C₄ cycle. In A. graecizans, increased with increasing [O₂] but tended to reach a maximum at relatively high O₂ levels. The lack of a linear increase in as previously observed for C₃ species indicates that a considerable amount of photorespired CO₂ may be re-fixed with increasing levels of O₂. In comparison to previous reports with other C₄ species, photosynthesis of A. graecizans shows greater sensitivity to O₂, with a noticeable inhibition occurring with shifts from 2 to 21% O₂. A. graecizans has characteristics of other C₄ species with respect to Kranz anatomy, localization of PEP carboxylase in mesophyll cells and RuBP carboxylase in bundle-sheath cells, and little fractionation among carbon isotopes during CO₂ fixation. The basis for the higher sensitivity of photosynthesis of A. graecizans to O₂ may be based upon a lower diffusive resistance of gases across bundle-sheath cells than in some other C₄ species.Abbreviations CE carboxylation efficiency - RuBP ribulose-1,5-bisphosphate - CO₂ compensation point     

Inhibition of platelet thromboxane synthetase by L-1-tosylamido-2-phenylethyl chloromethyl ketone

L-1-tosylamido-2-phenylethyl chloromethyl ketone (TPCK) was found to inhibit several aspects of arachidonic acid (20:4) metabolism in human platelets; the primary effect being inhibition of thromboxane synthetase. Thromboxane B₂ (TxB₂) formation from exogenous 20:4 or PGH₂, or from endogenous 20:4, was inhibited by TPCK at concentrations between 0.1 and 0.5 mM. Formation of malondialdehyde (MDA) and 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT), products which also arise from PGH₂, was inhibited to a similar extent. Inhibition of formation from 20:4 of 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE), the product of the lipoxygenase pathway, was observed; although the extent of this inhibition was less than that of TxB₂ formation. A small inhibitory effect of TPCK on the release of 20:4 from platelet phospholipids was also observed. This evidence indicated that while a number of reactions are inhibited by TPCK, the primary effect appears to be inhibition of thromboxane synthetase.     

Evidence for an Adenovirus Type 2-Coded Early Glycoprotein

We have identified an adenovirus type 2 (Ad2)-induced early glycopolypeptide with an apparent molecular weight of 20,000 to 21,000 (20/21K), as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The 20/21K polypeptide could be labeled in vivo with [(3)H]glucosamine. [(35)S]methionine- and [(3)H]-glucosamine-labeled 20/21K polypeptides bound to concanavalin A-Sepharose columns and were eluted with 0.2 M methyl-alpha-d-mannoside. The pulse-labeled polypeptide appeared as a sharp band with an apparent molecular weight of 21K, but after a chase it converted to multiple bands with an average molecular weight of 20K. This variability in electrophoretic mobility is consistent with glycosylation or deglycosylation of the 20/21K polypeptide. Analysis of the pulse and pulse-chase-labeled forms by using partial proteolysis indicated that the polypeptides were highly related chemically, but not identical. Most of the 20/21K polypeptide is localized in the cytoplasm fraction of infected cells lysed by Nonidet P-40. The 20/21K polypeptide and a 44K polypeptide, labeled with [(35)S]methionine or [(3)H]glucosamine in Ad2-infected human cells, were precipitated by a rat antiserum against an Ad2-transformed rat cell line (T2C4), but not by antisera against three other Ad2-transformed rat cell lines, or by serum from nonimmune rats. The partial proteolysis patterns of the 20/21K and the 44K polypeptides were indistinguishable, indicating that the two polypeptides are highly related, and suggesting that the 44K polypeptide might be a dimer of the 20/21K polypeptide. The 20/21K polypeptide was also induced in Ad2-early infected monkey and hamster cells. These results imply that the 20/21K polypeptide is synthesized in Ad2-infected human, monkey, and hamster cells, and in one but not all Ad2-transformed rat cells. Thus, the 20/21K polypeptide is probably viral coded rather than cell coded and viral induced.     

Removal of nitrate from water by cells ofParacoccus denitrificans in a membrane flow reactor

A new type of flow bioreactor designed to remove nitrate from water was developed. Denitrification activity of native Paracoccus denitrificans cells was used, the cells being separated from the refined medium by a semipermeable membrane. Relationships between the degree of nitrate conversion and the denitrification rate, on the one hand, and the volume flow rate and the amount of biomass, on the other, together with the results concerning denitrification during closed-circuit recirculation of the medium are discussed.     

Effect of N,N-Dicyclohexylcarbodiimide on Acetylcholine Release from Torpedo Synaptosomes and Proteoliposomes Reconstituted with the Proteolipid Mediatophore

The mediatophore is a presynaptic membrane protein that has been shown to translocate acetylcholine (ACh) under calcium stimulation when reconstituted into artificial membranes. The mediatophore subunit, a 15-kDa proteolipid, presents a very high sequence homology with the N,N'-dicyclohexylcarbodiimide (DCCD)-binding proteolipid subunit of the vacuolar-type H(+)-ATPase. This prompted us to study the effect of DCCD, a potent blocker of proton translocation, on calcium-dependent ACh release. The present work shows that DCCD has no effect on ACh translocation either from Torpedo synaptosomes or from proteoliposomes reconstituted with purified mediatophore. However, using [14C]DCCD, we were able to demonstrate that the drug does bind to the 15-kDa proteolipid subunit of the mediatophore. These results suggest that although the 15-kDa proteolipid subunits of the mediatophore and the vacuolar H(+)-ATPase may be identical, different domains of these proteins are involved in proton translocation and calcium-dependent ACh release and that the two proteins have a different membrane organization.     

Suppression of collagen arthritis with antibodies to an arthritogenic, oligoclonal T cell line.

Rats immunized with type II collagen (CII) develop an immunologically mediated polyarthritis. T cells have been implicated in the pathogenesis of this model since they can adoptively transfer the disease. A CII-specific T cell line (VA), consisting of three distinct clones by Southern blot analysis, has been shown to be arthritogenic. Antibodies specific for this line were generated by immunizing rabbits. In an attempt to prevent collagen-induced arthritis (CIA), Louvain rats were injected with 1 ml of anti-VA ip on Days -1, +1, +3 and 0.5 ml on Day +5 (early treatment). To evaluate its effect on existing disease, rats received anti-VA on the day of arthritis onset and subsequently on 4 successive alternate days using the same dosage protocol (late treatment). Control rats received no therapeutic injections or were administered normal rabbit serum. All rats were immunized with CII on Day 0 to induce CIA. Rats administered antibodies using the early anti-VA treatment protocol had a significantly diminished incidence of arthritis compared to controls. Established arthritis was significantly diminished compared to controls in rats given the late anti-VA treatment. In both protocols, radiographic evidence of joint destruction was significantly reduced compared to controls. T cell phenotyping using flow cytometry analysis demonstrated that the anti-VA antibody therapy selectively eliminated a small subset of T cells since there was little difference in total T cell counts in the experimental versus control groups. Delayed type hypersensitivity and IgG antibody titers to CII were minimally decreased in the experimental versus control group. These results suggest that antibodies raised to an oligoclonal arthritogenic T cell line can suppress collagen arthritis. This may have implications with respect to 1) the size of the T cell receptor repertoire involved in the pathogenesis of collagen arthritis and 2) immunospecific protocols for CIA and other autoimmune diseases.     

DNA sequence analysis of the lamB gene from Klebsiella pneumoniae: implications for the topology and the pore functions in maltoporin.

Summary We have determined the sequence of the lamB gene from Klebsiella pneumoniae. It encodes the precursor to the LamB protein, a 429 amino acid polypeptide with maltoporin function. Comparison with the Escherichia coli LamB protein reveals a high degree of homology, with 325 residues strictly identical. The N-terminal third of the protein is the most conserved part of the molecule (1 change in the signal sequence, and 13 changes up to residue 146 of the mature protein). Differences between the two mature proteins are clustered mainly in six regions comprising residues 145–167, 173–187, 197–226, 237–300, 311–329, and 367–387 (K. pneumoniae LamB sequence). The most important changes were found in regions predicted by the two-dimensional model of LamB folding to form loops on the cell surface. In vivo maltose and maltodextrin transport properties of E. coli K 12 and K. pneumoniae strains were identical. However, none of the E. coli K12 LamB-specific phages was able to plaque onto K. pneumoniae. Native K. pneumoniae LamB protein forms highly stable trimers. The protein could be purified by affinity chromatography on starch-Sepharose as efficiently as the E. coli K12 LamB protein, indicating a conservation of the binding site for dextrins. However, none of the monoclonal antibodies directed against native E. coli K12 LamB protein recognized native purified K. pneumoniae LamB protein. These data indicate that most of the variability occurs within exposed regions of the protein and provide additional support for the proposed model of LamB folding. The fact that the N-terminal third of the protein is highly conserved is in agreement with the idea that it is part of, or constitutes, the pore domain located within the transmembranous channel and that it is not accessible from the cell surface.